Home > Healthcare > Medical Devices > Diagnostic Devices > Retinal Detachment Diagnostic Market

Retinal Detachment Diagnostic Market – By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera), Disease (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment), End-use – Global Forecast (2024 – 2032)

  • Report ID: GMI9295
  • Published Date: Apr 2024
  • Report Format: PDF

Retinal Detachment Diagnostic Market Size

Retinal Detachment Diagnostic Market size was valued at USD 1.1 billion in 2023 and is anticipated to grow at a CAGR of 6.9% between 2024 – 2032. One of the primary drivers is the increasing incidence of retinal detachment globally, particularly among the aging population. As people age, the risk of developing retinal detachment increases, necessitating regular screenings and diagnostic tests.

Retinal Detachment Diagnostic Market

Additionally, the rising prevalence of predisposing factors such as myopia, eye surgeries, and trauma further fuels the demand for diagnostic solutions. Moreover, advancements in diagnostic technologies such as ophthalmoscopy, fundus photography, and fluorescent retinal angiography have significantly improved the accuracy and efficiency of diagnosing retinal detachment, thereby contributing to the market growth. Furthermore, growing awareness about eye health and the availability of advanced ophthalmic devices are expected to propel market growth in the coming years.

Retinal detachment diagnostics refer to the methods and procedures used by healthcare professionals to identify and confirm the detachment of the retina from its normal position within the eye. These diagnostic techniques are essential for detecting retinal detachment early, allowing for prompt treatment to prevent permanent vision loss. These help ophthalmologists assess the extent and severity of retinal detachment, guiding appropriate treatment decisions.

Retinal Detachment Diagnostic Market Trends

  • The rising geriatric population is a significant growth driver for the market. As people age, the risk of developing retinal detachment increases due to changes in the vitreous gel and other age-related factors that can lead to the pulling away of the retina from the underlying tissues.
  • Additionally, the elderly population is more prone to age-related eye conditions such as myopia, cataracts, and diabetic retinopathy, which further increases the risk of retinal detachment.
  • For instance, the prevalence of myopia in the elderly population is significantly high compared to young adults. In individuals aged 60-64 years, the prevalence ranges from 22.74% to 28.7%, while in those aged 80 years and above, it increases to 45.58% to 19.3%. Similarly, as per the CDC, an estimated 8.94 million people aged 40 years and older were living with diabetic retinopathy in 2021, and 1.71 million of those were living with vision-threatening diabetic retinopathy.
  • Thus, with the global population aging rapidly, the demand for retinal detachment diagnostics is expected to increase, driving market growth.

Retinal Detachment Diagnostic Market Analysis

Retinal Detachment Diagnostic Market, By Diagnostics, 2021 – 2032 (USD Billion)

Based on diagnostics, the market is segmented into digital retinal camera, fundus photography, ophthalmoscopy, fluorescent retinal angiography, and other diagnostics. The digital retinal camera segment dominated the market is 2023 and accounted for USD 370.6 million.

  • The digital retinal camera holds a significant share in the market due to its superior imaging capabilities, non-invasive nature, ease of use, and efficiency in capturing images.
  • These cameras provide high-resolution images of the retina, allowing for detailed examination of the retina's condition and aiding in the early detection of retinal detachment.
  • Additionally, advancements in digital imaging technology, such as improved image quality and integration with electronic medical records, have further boosted the adoption of digital retinal cameras for retinal detachment diagnosis, thereby boosting the segmental growth.


Retinal Detachment Diagnostic Market, By Disease (2023)

Based on disease, the retinal detachment diagnostic market is segmented into rhegmatogenous retinal detachment, exudative, serous, or secondary retinal detachment, and tractional retinal detachment. The rhegmatogenous retinal detachment segment dominated the market with 48.4% of market share in 2023.

  • Rhegmatogenous retinal detachment (RRD) is the most common form of retinal detachment and requires prompt diagnosis and treatment to prevent vision loss.
  • Factors such as aging populations and rising global prevalence of myopia are major risk factors contributing to rhegmatogenous retinal detachment.
  • Additionally, RRD often requires prompt and accurate diagnosis for timely surgical intervention, further driving the demand for effective diagnostic tools and techniques, thereby driving the segmental growth.

Based on end-use, the retinal detachment diagnostic market is categorized into hospitals, ophthalmic clinics, and other end-users. The hospitals segment dominated the market in 2023 and is predicted to grow at a CAGR of 6.8% over the forecast period.

  • Hospitals are often the primary point of care for individuals experiencing symptoms of retinal detachment, leading to a high volume of diagnostic procedures being conducted in these settings.
  • Moreover, hospitals typically have access to advanced diagnostic technologies which are crucial for accurate diagnosis of retinal detachment.
  • Additionally, a steady influx of patients requiring retinal detachment diagnosis, further solidifies their position as key end-users in this market.


North America Retinal Detachment Diagnostic Market, 2021 – 2032 (USD Million)

North America retinal detachment diagnostic market is anticipated to grow at a CAGR of 6.5% over the forecast years to reach USD 750.2 million by 2032.

  • The region's advanced healthcare infrastructure, coupled with high healthcare expenditure, contributes to the accessibility and adoption of retinal detachment diagnostics.
  • Moreover, the region's strong research and development capabilities lead to the continuous innovation of diagnostic technologies, further propelling market growth.
  • Furthermore, with a growing aging population prone to retinal disorders and a high prevalence of diabetes, a major risk factor for retinal detachment, North America is poised to maintain its dominant position in the market.

U.S. retinal detachment diagnostic market was valued at USD 389.5 million in 2023.

  • The presence of advanced healthcare infrastructure and sophisticated medical technology facilitates early detection and diagnosis, thereby driving demand for effective diagnostics.
  • Additionally, the country boasts a large pool of skilled ophthalmologists and retina specialists who are adept at diagnosing retinal detachment, further bolstering market growth.
  • Furthermore, strong healthcare reimbursement policies and insurance coverage encourage patients to seek timely diagnosis, thereby fostering market expansion.
  • Lastly, the presence of key market players investing in research and development activities to introduce innovative diagnostic solutions enhances the growth prospects in this region.

Germany has emerged as a key player in the global market for retinal detachment diagnostic, showcasing high growth potential.

  • The country's advanced healthcare infrastructure, particularly in ophthalmology, enables early detection and diagnosis of retinal detachment.
  • Additionally, the presence of a large elderly population, which is more susceptible to retinal issues, increases the demand for effective diagnostics.
  • Lastly, Germany's strong healthcare reimbursement system ensures that patients have access to affordable diagnostic procedures, further boosting market growth.

China retinal detachment diagnostic market is anticipated to witness lucrative growth between 2024 – 2032.

  • The country's large population, particularly the aging demographic, is prone to age-related eye disorders like retinal detachment, driving the demand for diagnostic services.
  • Additionally, the expanding healthcare infrastructure in the country coupled with rising disposable incomes are making advanced diagnostic technologies more accessible, thereby fueling market growth.
  • Moreover, several government's initiatives to improve healthcare services and increase awareness about eye diseases further stimulates market expansion.

Retinal Detachment Diagnostic Market Share

The competitive landscape of the retinal detachment diagnostics market is characterized by a diverse array of players vying for market share through innovation and strategic partnerships. Established multinational companies such as Carl Zeiss Meditec AG, Canon Medical Systems Corporation, and Essilor International dominate the market with their extensive product portfolios and strong distribution networks. These companies continually invest in research and development to introduce advanced diagnostic technologies, aiming to capture a larger market share. Additionally, collaborations between healthcare institutions, academic research centers, and industry players are fostering the development of novel diagnostic tools and techniques, intensifying competition in the market.

Retinal Detachment Diagnostic Market Companies

Prominent players operating in the retinal detachment diagnostic industry include:

  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • Centervue SpA.
  • Essilor International
  • Eyenuk Inc.
  • HealPros LLC
  • Millennium Surgical Corp.
  • ONL Therapeutics
  • Peek Vision Ltd
  • Synergy Medical Systems LLP

Retinal Detachment Diagnostic Industry News:

  • In December 2023, Carl Zeiss Meditec AG entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.). This acquisition complemented ZEISS Medical Technology’s broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions.
  • In September 2019, Canon Medical Systems Europe introduced the Xephilio OCT-S1, the industry's first wide-field swept source optical coherence tomography (OCT) capable of capturing high-resolution images of up to 23 mm in a single scan. This helped the company to expand its eye care portfolio and provided clinicians with a powerful tool for comprehensive eye examinations and diagnostics.

The retinal detachment diagnostic market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Diagnostics

  • Digital retinal camera
  • Fundus photography
  • Ophthalmoscopy
  • Fluorescent retinal angiography
  • Other diagnostics

Market, By Disease

  • Rhegmatogenous retinal detachment
  • Exudative, serous, or secondary retinal detachment
  • Tractional retinal detachment

Market, By End-use

  • Hospitals
  • Ophthalmic clinics
  • Other end-users

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global retinal detachment diagnostic market was valued at USD 1.1 billion in revenue in 2023 and is anticipated to grow at 6.9% CAGR between 2024 – 2032, driven by the increasing incidence of retinal detachment worldwide.

The rhegmatogenous retinal detachment segment held 48.4% of the retinal detachment diagnostic industry share in 2023, owing to the rising aging population and increasing prevalence of myopia.

North America retinal detachment diagnostic market size is anticipated to reach USD 750.2 million by 2032, attribute to the advanced healthcare infrastructure, coupled with high healthcare expenditure.

Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Centervue SpA., Essilor International, Eyenuk Inc., HealPros LLC, Millennium Surgical Corp., ONL Therapeutics, Peek Vision Ltd and Synergy Medical Systems LLP

Retinal Detachment Diagnostic Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 213
  • Countries covered: 22
  • Pages: 116
 Download Free Sample